Crimean–Congo hemorrhagic fever (CCHF) is a dangerous viral illness spread by ticks and livestock; it can cause sudden fever, organ failure and internal bleeding, and there are no approved vaccines or specific treatments. A new mouse study published in npj Vaccines reports promising results for an experimental vaccine developed by a team that includes Scott Pegan at the University of California, Riverside.
The vaccine uses a virus-like replicon particle. It mimics how a virus enters cells but lacks the genetic material needed to replicate, so it cannot cause infection. The team previously showed one dose could protect animals within three days. The new study measured antibody responses after one or two doses and found antibodies detectable for up to 18 months, an interval the authors say roughly equals several human years. Antibody levels were similar between one- and two-dose groups for about nine months; a booster produced stronger, more stable antibodies and longer protection.
The vaccine focuses on internal viral proteins, especially the N protein, normally hidden inside the virus and important for immunity. Researchers aim to move to large-scale production under Good Manufacturing Practice before human trials. Partners at the CDC are already exploring the platform for other pathogens.
Difficult words
- hemorrhagic — causing severe bleeding inside the body
- replicon — a viral particle that cannot make full copies
- antibody — a blood protein that fights infectionsantibodies
- booster — an extra vaccine dose to increase protection
- platform — a system or method used for development
- pathogen — an organism that causes disease in peoplepathogens
- replicate — to make more copies of itself
- immunity — protection in the body against disease
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why might it be important that the vaccine cannot replicate in the body?
- Would you feel more confident about a vaccine that gives detectable antibodies for 18 months? Why or why not?
- How could using the same vaccine platform for different pathogens help public health?
Related articles
Some processed foods may be addictive
Researchers say many ultraprocessed products — like snacks, sugary drinks and fast food — share addictive qualities with tobacco. The study urges a shift from blaming individuals toward policies that hold companies accountable for engineered, habit-forming foods.
Depression test works for people with chronic pain
Researchers found that a common eight-question depression test gives similar results for people with and without chronic pain. The study used a large 2019 US health survey and says clinicians can trust positive screens in patients with pain.
How social media in China shapes eating disorders
Online communities on platforms like Xiaohongshu use codes and posts that normalise strict eating and extreme thinness. Research shows more Chinese teenagers now show signs of eating disorders and experts say removal of posts is not enough.